GB201906804D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB201906804D0
GB201906804D0 GBGB1906804.8A GB201906804A GB201906804D0 GB 201906804 D0 GB201906804 D0 GB 201906804D0 GB 201906804 A GB201906804 A GB 201906804A GB 201906804 D0 GB201906804 D0 GB 201906804D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1906804.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Biopharma SRL
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Priority to GBGB1906804.8A priority Critical patent/GB201906804D0/en
Publication of GB201906804D0 publication Critical patent/GB201906804D0/en
Priority to PCT/EP2020/063083 priority patent/WO2020229427A1/en
Ceased legal-status Critical Current

Links

GBGB1906804.8A 2019-05-14 2019-05-14 Therapeutic agents Ceased GB201906804D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1906804.8A GB201906804D0 (en) 2019-05-14 2019-05-14 Therapeutic agents
PCT/EP2020/063083 WO2020229427A1 (en) 2019-05-14 2020-05-11 Antimalarial hexahydropyrimidine analogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1906804.8A GB201906804D0 (en) 2019-05-14 2019-05-14 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB201906804D0 true GB201906804D0 (en) 2019-06-26

Family

ID=67384656

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1906804.8A Ceased GB201906804D0 (en) 2019-05-14 2019-05-14 Therapeutic agents

Country Status (2)

Country Link
GB (1) GB201906804D0 (en)
WO (1) WO2020229427A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021026884A1 (en) * 2019-08-15 2021-02-18 Merck Sharp & Dohme Corp. Antimalarial agents
GB202010606D0 (en) 2020-07-10 2020-08-26 Ucb Biopharma Sprl Therapeutic agents
WO2023152042A1 (en) 2022-02-08 2023-08-17 UCB Biopharma SRL Antimalarial hexahydropyrimidine analogues

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
CN101671307B (en) 2003-12-15 2014-05-14 默沙东公司 Heterocyclic aspartyl protease inhibitors
UA108363C2 (en) 2009-10-08 2015-04-27 IMINOTIADIASIADIOXIDE OXIDES AS BACE INHIBITORS, COMPOSITIONS THEREOF AND THEIR APPLICATIONS
WO2016118404A1 (en) 2015-01-20 2016-07-28 Merck Sharp & Dohme Corp. Iminothiadiazine dioxides bearing an amine-linked substituent as bace inhibitors, compositions, and their use
KR20170139060A (en) 2015-04-21 2017-12-18 올제네시스 바이오테라퓨틱스 아이엔씨. Compounds as BACE1 Inhibitors and Their Uses
JP6826116B2 (en) 2015-11-25 2021-02-03 ユーシービー バイオファルマ エスアールエル Iminotetrahydropyrimidinone derivative as a plasmepsin V inhibitor
WO2017142825A2 (en) 2016-02-18 2017-08-24 Merck Sharp & Dohme Corp. N3-substituted iminopyrimidinones as antimalarial agents
GB201603104D0 (en) 2016-02-23 2016-04-06 Ucb Biopharma Sprl Therapeutic agents
GB201805816D0 (en) 2018-04-06 2018-05-23 Ucb Biopharma Sprl Therapeutic agents

Also Published As

Publication number Publication date
WO2020229427A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
GB201909190D0 (en) Therapeutic agents
GB201909191D0 (en) Therapeutic agents
GB201909194D0 (en) Therapeutic agents
GB201820166D0 (en) Therapeutic agents
GB201820165D0 (en) Therapeutic agents
GB201902277D0 (en) Therapeutic agents
GB201805816D0 (en) Therapeutic agents
GB201900702D0 (en) Therapy
GB201906804D0 (en) Therapeutic agents
IL288237A (en) Combination therapy
GB201906864D0 (en) Combination therapy
GB201913759D0 (en) Therapeutic agents
GB201911865D0 (en) Therapeutic agents
GB201911712D0 (en) Therapeutic agents
GB201820160D0 (en) Therapeutic agents
GB201820162D0 (en) Therapeutic agents
GB201820168D0 (en) Therapeutic agents
GB201820170D0 (en) Therapeutic agents
GB201820172D0 (en) Therapeutic agents
GB201820164D0 (en) Therapeutic agents
GB201811753D0 (en) Therapeutic agents
GB201811467D0 (en) Therapeutic agents
GB201800639D0 (en) Therapeutic agents
ZA202200731B (en) Combination therapy
GB201919036D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)